1Y Close · As of Aug 26, 2026
CORESTEMCHEMON operates in the Pharmaceuticals sector.
Legal name: CORESTEMCHEMON Inc.
In fiscal year 2025, CORESTEMCHEMON (166480) reported revenue of 20.2 billion KRW, down 29.9% from 28.8 billion KRW a year earlier.
Operating profit was -21.2 billion KRW and net income was -26.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 107.9 billion KRW, with a P/B of 1.95.
These figures can be verified in the DART filing (receipt no. 20260319001127).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 20.2B | -21.2B | -26.8B |
| 2024 | 28.8B | -22.0B | -26.3B |
| 2023 | 33.7B | -19.7B | -17.7B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |